• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,499.17 129.78
(0.25%)
Dow Jones
7,562.80 59.09
(0.79%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,472.08 -16.96
(-0.16%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Shetron Ltd
Industry :  Packaging
BSE Code
ISIN Demat
Book Value()
526137
INE278C01010
68.5777778
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHETRON
21.96
82.22
EPS(TTM)
Face Value()
Div & Yield %
4.16
10
1.09
 

Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
May 13,2026
Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.87 crore during the previous quarter ended March 2025. Sales rose 2.15% to Rs 995.30 crore in the quarter ended March 2026 as against Rs 974.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.69% to Rs 1035.98 crore in the year ended March 2026 as against Rs 927.58 crore during the previous year ended March 2025. Sales rose 1.93% to Rs 3821.67 crore in the year ended March 2026 as against Rs 3749.21 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales995.30974.37 2 3821.673749.21 2
OPM %35.2634.20 -34.2631.40 -
PBDT386.27373.29 3 1451.831321.98 10
PBT373.10358.57 4 1385.391255.19 10
NP277.86262.87 6 1035.98927.58 12